Drug profile

The FDA adverse-event record for Tick Collar

47 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Tick Collar. See the species affected, top reactions, and outcomes below.

47
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
20
Emesis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
47
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Tick Collar

Administration Routes

UnknownTopicalCutaneousOther

Species Affected

Dog 46
Unknown 1

Most Affected Breeds

Crossbred Canine/dog 4
Retriever - Labrador 4
Boxer (German Boxer) 4
Dog (unknown) 4
Beagle 3
Retriever - Golden 3
Terrier - Silky 2
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 2
Retriever (unspecified) 2
Shepherd Dog - Australian 2

Most Reported Reactions

Emesis 20
Lethargy (see also Central nervous system depression in 'Neurological') 7
Lack of efficacy (ectoparasite) - flea 6
Scratching 4
Lack of efficacy - NOS 4
Crying 3
Head shake - ear disorder 3
Shaking 3
Seizure NOS 3
Vomiting 3
Behavioural disorder NOS 2
Not sleeping 2

Outcome Breakdown

Recovered/Normal
33 (71.7%)
Outcome Unknown
11 (23.9%)
Recovered with Sequela
2 (4.3%)

Tick Collar Adverse Event Insights

47 reports name Tick Collar; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Tick Collar. Administration routes: Unknown, Topical, Cutaneous, Other.

By species: Dog (46 reports), Unknown (1 reports). By breed: Crossbred Canine/dog (4), Retriever - Labrador (4), Boxer (German Boxer) (4).

Leading clinical signs: Emesis (20), Lethargy (see also Central nervous system depression in 'Neurological') (7), Lack of efficacy (ectoparasite) - flea (6), Scratching (4). Outcome, 46 coded reports: Recovered/Normal leads at 71.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.